C-reactive protein and model for end-stage liver disease score: Have we found the fifth element?

Liver Transplantation

Volumn 21, Issue 6, 2015, Pages 713-715

  Ruf, Andres E ^a,b   Villamil, Federico G ^a,b,c  

^a HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

^b FUNDIEH Fundación para la Docencia e Investigación de las Enfermedades del Hígado   (Argentina)

^c El Cruce Hospital ^*  (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

DISEASE COURSE; EDITORIAL; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER TRANSPLANTATION; MODEL FOR END STAGE LIVER DISEASE SCORE; PRIORITY JOURNAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; BLOOD; FEMALE; MALE; METABOLISM;

C-REACTIVE PROTEIN; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE;

EID: 84930047136     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24140     Document Type: Editorial

References (12)

1. D'Amico G, Garcia-Tsao G, Pagliaro L,. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006; 44: 217-231.
2. Kamath PS, Kim WR,; for Advanced Liver Disease Study Group. The Model for End-Stage Liver Disease (MELD). Hepatology 2007; 45: 797-805.
3. Olthoff KM, Brown RS Jr, Delmonico FL, Freeman RB, McDiarmid SV, Merion RM, et al., Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. Liver Transpl 2004; 10 (suppl 2): A6-A22.
4. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG,. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 2005; 11: 336-343.
5. Biggins SW,. Use of serum sodium for liver transplant graft allocation: a decade in the making, now is it ready for primetime? Liver Transpl 2015; 21: 279-281.
6. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al.,; for CANONIC Study Investigators of the EASL-CLIF Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144: 1426-1437.
7. Thabut D, Massard J, Gangloff A, Carbonell N, Francoz C, Nguyen-Khac E, et al., Model for End-Stage Liver Disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology 2007; 46: 1872-1882.
8. Cazzaniga M, Dionigi E, Gobbo G, Fioretti A, Monti V, Salerno F,. The systemic inflammatory response syndrome in patients with cirrhosis: relationship with their in-hospital outcome. J Hepatol 2009; 51: 475-482.
9. Malik R, Mookerjee RP, Jalan R,. Infection and inflammation in liver failure: two sides of the same coin. J Hepatol 2009; 51: 426-429.
10. Pieri G, Agarwal B, Burroughs AK,. C-reactive protein and bacterial infection in cirrhosis. Ann Gastroenterol 2014; 27: 113-120.
11. Cervoni JP, Thévenot T, Weil D, Muel E, Barbot O, Sheppard F, et al., C-reactive protein predicts short-term mortality in patients with cirrhosis. J Hepatol 2012; 6: 1299-1304.
12. Di Martino V, Coutris C, Cervoni JP, Dritsas S, Weil D, Richou C, et al., Prognostic value of C-reactive protein levels in patients with cirrhosis. Liver Transpl 2015; 21.